ASX Health stocks: Neuren soars 30% in early Christmas present after Phase 2 trial success
Shares hit $22.70 after Phase II Results ,,, Orphan Drug Designation Awarded...
Ton of Media , Editorial was with all the Investment Sites... Great to see significant returns for Scientific Progress...
- Forums
- ASX - By Stock
- PAA
- Ann: PharmAust Launches Interactive Investor Hub
Ann: PharmAust Launches Interactive Investor Hub, page-17
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
18.8¢ |
Change
-0.008(3.85%) |
Mkt cap ! $83.22M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 18.5¢ | $304.2K | 1.603M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 536316 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 91705 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 536246 | 0.185 |
17 | 499949 | 0.180 |
9 | 765343 | 0.175 |
6 | 182940 | 0.170 |
4 | 88000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 91705 | 3 |
0.195 | 82558 | 7 |
0.200 | 346149 | 3 |
0.205 | 75528 | 6 |
0.210 | 311836 | 4 |
Last trade - 13.24pm 28/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online